The pharmaceutical landscape in the nation is increasingly characterized by a appearance toward market concentration, with a handful of prominent companies wielding significant power. These sector giants, often bolstered by established distribution networks and strong brand recognition, present a difficult picture for competition and accessible hea

The Indian pharmaceutical industry, known for its affordable and accessible medicines, faces rising concerns about monopolies. A few dominant companies control a significant portion of the market, potentially restricting competition and driving up prices for consumers. This concern raises questions about the long-term impact on patient access to a